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Abstract
Heme oxygenase-1 (HO-1) is an enzyme that catabolizes free heme, which induces an intense inflammatory
response. The expression of HO-1 is induced by different stimuli, triggering an anti-inflammatory response during
biological stress. It was previously verified that HO-1 is able to induce indoleamine 2,3-dioxygenase (IDO), an
enzyme that is induced by IFN-γ in Toxoplasma gondii infection. To verify the role of HO-1 during in vivo T. gondii
infection, BALB/c and C57BL/6 mice were infected with the ME49 strain and treated with zinc protoporphyrin IX
(ZnPPIX) or hemin, which inhibit or induce HO-1 activity, respectively. The results show that T. gondii infection
induced high levels of HO-1 expression in the lung of BALB/c and C57BL6 mice. The animals treated with ZnPPIX
presented higher parasitism in the lungs of both lineages of mice, whereas hemin treatment decreased the parasite
replication in this organ and in the small intestine of infected C57BL/6 mice. Furthermore, C57BL/6 mice infected
with T. gondii and treated with hemin showed higher levels of IDO expression in the lungs and small intestine than
uninfected mice. In conclusion, our data suggest that HO-1 activity is involved in the control of T. gondii in the
lungs of both mouse lineages, whereas the hemin, a HO-1 inducer, seems to be involved in the control of
parasitism in the small intestine of C57BL/6 mice.
Introduction
Toxoplasma gondii is an obligate intracellular parasite
that infects humans and animals worldwide [1]. All
mammals and birds that are consumed by humans may
serve as intermediate hosts for T. gondii and, thus, may
be a potential source of infection for humans [2]. In live-
stock, T. gondii tissue cysts are most frequently observed
in various tissues of infected pigs, sheep and goats, and
less frequently in infected poultry, rabbits, dogs and
horses. By contrast, tissue cysts are found only rarely in
skeletal muscles of cattle or buffaloes [3]. Although
toxoplasmosis is a serious disease of humans, sheep, and
many other warm-blooded animals [4], only a small
percentage of exposed adult humans or animals develop
clinical signs of the disease [5,6]. Toxoplasmosis is more
severe in immunocompromised individuals and in cases
of congenital infection [7]. The parasite is able to spread
to all tissues and each tissue compartment has its own
specific immune response [8].
Virtually all mouse lineages develop a Th1-type im-
mune response to T. gondii, regardless of whether they
present resistant or susceptible major histocompatibility
complex (MHC) haplotypes [9,10]. However, a tight im-
munoregulation is necessary to prevent immunopathol-
ogy [11-13]. Despite the type 1 immune response,
C57BL/6 mice are more susceptible to the parasite than
BALB/c mice [14-16]. The resistance to brain cyst bur-
den and development of toxoplasmic encephalitis in
mice were mapped to the regions D and L of MHC class
I genes, more precisely the Ld (H-2d) region. Thus,
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mortality is substantially greater in mice that have H-2b
(C57BL/6) than in mice possessing an H-2d (BALB/c)
background [17-20].
T. gondii infection induces IFN-γ production that is
important to control parasite replication [21], and the
toxoplasmacidal activity is associated to high levels of
IFN-γ-triggered nitric oxide (NO) [22]. IFN-γ is also able
to induce the enzyme indoleamine 2,3-dioxygenase
(IDO), which degrades tryptophan, an essential amino
acid for T. gondii growth [23]. During the early stage of
T. gondii infection in the mouse model, IDO expression
and tryptophan degradation are induced by endogenous
IFN-γ [24,25].
Heme oxygenase (HO) is a stress-responsive enzyme
that degrades free heme (iron protoporphyrin IX) to
three products: gas carbon monoxide (CO), iron that
induces the expression of heavy-chain (H-) ferritin
(an iron-sequestering protein) and biliverdin, which is
converted to bilirubin by biliverdin reductase (BVR)
[26,27]. To date, three isoforms (HO-1, HO-2, and
HO-3) that catalyze this reaction have been identified
[24]. Under normal physiological conditions, most cells
express low or undetectable levels of HO-1, while HO-2
is constitutively expressed [28,29].
The principal function of HO-1 is to avoid the accu-
mulation of free heme [28], and HO-1 is inducible by
numerous stimuli, such as NO, cytokines and growth
factors, metalloporphyrins, hydrogen peroxide and lipid
metabolites (reviewed in [30]). Although the function of
this enzyme is still incompletely understood, previous
studies suggest that the endogenous induction of
HO-1 provides cytoprotective [31,32], anti-inflammatory
[33,34] and anti-apoptotic [35] effects. The role of HO-1
is important in a broad range of inflammatory diseases,
such as a sepsis model [36], airway inflammation [37]
and virus infection [38]. HO-1 plays an important role
in suppressing malaria pathology, since high expression
of HO-1 is able to control susceptibility to cerebral mal-
aria in mice [39]. From this aspect, BALB/c mice, which
are less likely to develop experimental cerebral malaria
(ECM) when infected with Plasmodium berghei, have a
higher HO-1 expression than C57BL/6 mice, which de-
velop ECM [39]. In contrast, HO-1 enzyme is necessary
for the establishment of malaria liver stage; indeed HO-1
overexpression is associated with P. berghei liver infec-
tion, an effect that seems to be mediated by controlling
the host inflammatory response [40]. Similarly, infec-
tions with Leishmania pifanoi parasites avoid the elicit-
ation of superoxide production in infected macrophages
by inducing HO-1 levels [41]. On the contrary, HO-1
expression seems to be involved in controlling parasit-
ism in Trypanosoma cruzi infected mice [42].
The aim of the present study was to investigate the ef-
fect of HO-1 inhibition and induction during T. gondii
infection in both resistant (BALB/c) and susceptible
(C57BL/6) mouse lineages, considering the role of HO-1
during infectious diseases caused by protozoan parasites.
Materials and methods
Parasite strains
The ME49 strain of T. gondii was used to infect animals
in this study. The strain was maintained in Swiss mice,
which were inoculated by the intraperitoneal (i.p.) route
with 20 cysts of T. gondii. A month after the inoculation,
the brain cysts were collected and used to infect the
animals.
For in vitro experiments, T. gondii tachyzoites of the
2 F1 strain, which constitutively express cytoplasmic
β-galactosidase and are derived from the RH strain, were
a gift from Dr Vern Carruthers, Medicine School of
Michigan University (USA). The parasites were propa-
gated in human uterine cervical (HeLa) cells obtained
from the American Type Culture Collection (ATCC,
Manassas, VA, USA) and maintained in RPMI 1640
medium (Cultilab, Campinas, SP, Brazil) supplemented
with 100 U/mL penicillin, 100 μg/mL streptomycin (both
reagents from Sigma Chemical Co., St. Louis, MO, USA)
and 2% heat-inactivated fetal calf serum (FCS) (Cultilab)
in a humidified incubator at 37 °C and 5% CO2.
Animals
Female adult (8-12 week old) C57BL/6 and BALB/c mice
were purchased from the School of Medicine of Ribeirão
Preto, University of São Paulo, SP, Brazil and maintained
under standard conditions in the Animal Experimen-
tation Laboratory, Institute of Biomedical Sciences,
Federal University of Uberlândia, MG, Brazil. All experi-
mental procedures were approved by the Animal Experi-
mental Ethics Committee (CEUA) of the Federal
University of Uberlândia, with protocol number 007/09.
Inhibition/induction of HO activity and T. gondii infection
ZnPPIX (Sigma) and hemin (Sigma) were used for inhib-
ition and induction of the activity of HO, respectively. The
reagents were dissolved in 50 mM Na2CO3 (pH 9.0) and
the final volume was adjusted to an equal volume of 0.85%
NaCl. C57BL/6 and BALB/c mice were treated subcutane-
ously with ZnPPIX (10 mg/kg/day), or hemin (5 mg/kg/
day), or vehicle (Na2CO3 +NaCl - control group).
One day after the beginning of the treatment, C57BL/6
and BALB/c mice were infected with 5 cysts of T. gondii
by the oral route as previously described [43-45] and were
treated for an additional 11 days with ZnPPIX or hemin
or vehicle. The animals were observed daily for morbidity
and body weight changes. Morbidity scores were calcu-
lated as described elsewhere [46], as follows: sleek/glossy
coat, bright and active (score 0); ruffled coat, hunched, tot-
tering gait, reluctance to move (score 1); starry stiff coat
Araujo et al. Veterinary Research 2013, 44:89 Page 2 of 14
http://www.veterinaryresearch.org/content/44/1/89
(score 2). At 12 days post-infection (dpi), when the ani-
mals presented high morbidity scores, groups of six mice
were anesthetized with ketamine (Syntec Brasil Ltda,
Cotia, SP, Brazil) and Xylazine (Schering-Plough Coopers,
Cotia, SP, Brazil) by the i.p. route and were killed by cer-
vical dislocation. Blood samples were collected for sero-
logical assays and tissue samples, such as lung, liver, small
intestine and brain, were collected, fixed in 10% buffered
formalin, and processed routinely for paraffin embedding
and sectioning or frozen immediately and stored in -80 °C
for western blotting analysis.
Determination of bilirubin levels in serum samples
In order to confirm the inhibition or induction of HO-1
activity in vivo, bilirubin, a secondary product of the en-
zyme activity, was measured in serum samples of treated
mice by using an analytic kit (Labtest, Lagoa Santa, MG,
Brazil) according to the manufacturer’s instructions. The
absorbance was obtained at 520 nm and the bilirubin
levels expressed in mg/dL.
Quantification of tissue parasitism and HO-1 expression
by immunohistochemistry
The parasitism and HO-1 expression was evaluated in the
organs by immunohistochemistry as previously described
[47]. Deparaffinized sections were incubated at room
temperature with phosphate buffered saline (PBS) plus 3%
non-fat milk (Nestle, São Paulo, SP, Brazil) to reduce
nonspecific binding and then incubated at 4 °C overnight
with polyclonal anti-T. gondii serum (obtained from
Calomys callosus infected with ME49 strain) or goat anti-
HO-1 antibody (Santa Cruz Biotechnology, Santa Cruz, CA,
USA) both diluted in 0.01% saponin. After incubation with
biotinylated goat anti-mouse antibody (Sigma) that recog-
nizes C. callosus immunoglobulin or biotin-labeled donkey
anti-goat antibody (Jackson ImmunoResearch Laboratories,
West Grove, PA, USA), the assay sensitivity was improved
by adding avidin-biotin-peroxidase complex (ABC kit,
PK-4000; Vector Laboratories, Inc., Burlingame, CA, USA).
The reaction was developed with 0.03% H2O2 plus 3,3′-
diaminobenzidine tetrahydrochloride (DAB; Sigma) for
5 min. The sections were counterstained with Harris haema-
toxylin and examined under a light microscope using a 40×
objective. The tissue parasitism was scored by counting the
number of cyst-like structures and parasitophorous vacuoles
from fifty microscopic fields in the lung and small intestine
or per tissue section in the liver and brain in two histological
sections of each mouse and from six mice per group.
Cytokine (TNF-α, IFN-γ, TGF-β and IL-10), HO-1 and IDO
mRNA expression in tissue samples by quantitative PCR
(qPCR)
Fragments containing 100 mg were obtained from the
lungs or ilea. RNA was extracted using an RNA extraction
kit (Promega, Madison, WI, USA), according to the manu-
facturer’s instructions. The RNA concentration was deter-
mined (Biomate 3 spectrophotometer Thermospectronic,
Rochester, NY, USA) and complementary DNA (cDNA)
was synthesized using 1 μg of RNA through a reverse
transcription reaction (M-MLV reverse transcriptase,
Promega). Real-PCR quantitative mRNA analyses were
performed on the ABI Prism 7500 Sequence Detection
System using SYBR green fluorescence (Applied Biosys-
tems, Warrington, UK). The standard PCR conditions
were 95 °C for 10 min, 40 cycles for 1 min at 94 °C, 56 °C
(1 min) and 72 °C (2 min), followed by a standard denatur-
ation curve. The sequences of murine primers were
designed using the Primer Express software (Applied
Biosystems) and nucleotide sequences present in the
GenBank database (Table 1). SYBR Green PCR Master
Mix (Applied Biosystems), 0.1-0.2 μg/μL of specific
primers, and 2.5 ng of cDNA were used in each reaction.
The results were demonstrated as mRNA expression rela-
tive to non-infected mice. Calculations to determine the
relative level of gene expression were made according to
the instructions from Applied Biosystems User’s Bulletin
#2 (P/N 4303859), with reference to β-actin in each sam-
ple, using the threshold cycle (Ct) method. Negative con-
trols without cDNA were also performed.
Detection of IDO protein in tissue homogenate by
Western blotting
Fragments of lung and small intestine from BALB/c and
C57BL/6 mice were dissected, washed in saline, frozen
in liquid nitrogen, and stored at -80 °C until use. The tis-
sue samples were pulverized in liquid nitrogen and
promptly homogenized in extraction buffer (40 mM
HEPES pH 7.7, 5 mM EDTA pH7.4, 1 mM benzamidine,
Table 1 Primer sequences used in real time PCR assays
Primers Sequences
β-actin Sense AGC TGC GTT TTA CAC CCT TT
Antisense AAG CCA TGC CAA TGT TGT CT
TNF Sense TGT GCT CAG AGC TTT CAA CAA
Antisense CTT GAT GGT GGT GCA TGA GA
IFN-γ Sense GCA TCT TGG CTT TGC AGC T
Antisense CCT TTT TCG CCT TGC TGT TG
IL-10 Sense TGG ACA ACA TAC TGC TAA CC
Antisense GGA TCA TTT CCG ATA AGG CT
TGF-β Sense TGA ACC AAG GAG ACG GAA TAC A
Antisense GGA GTT TGT TAT CTT TGC TGT CAC A
HO-1 Sense CCC AAA ACT GGC CTG TAA AA
Antisense CGT GGT CAG TCA ACA TGG AT
IDO Sense GGC AAA CTG GAA GAA AAA GG
Antisense CAC CAG GAA ATG GAA CAG AAT G
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10 μg/mL aprotinin, 0.5 mM phenylmethane sulfonyl-
fluoride, 2 mM dithiothreitol) and centrifuged at 15
000 × g for 5 min at 4 °C. The supernatants were col-
lected, and the concentration of protein was measured
by Bradford assay [48].
Protein samples (20 μg) were subjected to polyacryl-
amide gel electrophoresis under denaturing conditions
(SDS-PAGE) at 10% and electrotransferred to PVDF
membranes (Merck Millipore Headquarters, Billerica,
MA, USA). Blotted membranes were incubated in
blocking buffer (5% non-fat milk in 20 mM Tris buffered
saline, pH 7.4 [TBS]) for 2 h at room temperature and
incubated overnight with rat polyclonal anti-IDO anti-
body (Santa Cruz Biotechnology) or mouse monoclonal
anti-β-actin antibody (Santa Cruz Biotechnology) at
1:200 or 1:1000 in TBS, respectively. Next, the mem-
branes were exposed to peroxidase labeled goat anti-rat
(Jackson ImmunoResearch Laboratories) diluted at
1:1000 for IDO detection or peroxidase labeled goat
anti-mouse (Sigma) diluted at 1:3000 for β-actin detec-
tion in TBS with 1% non-fat milk, for 2 h at room
temperature. The reaction was revealed by chemilumin-
escence (ECL kit, GE Healthcare, São Paulo, SP, Brazil)
and an equal loading of the proteins was confirmed by
staining the blots with 1% Ponceau. Densitometric ana-
lyses were performed by using the KODAK software (1D
Image Analysis Software 3.5) in order to determine the
mean intensity of the bands. The data were demon-
strated as the relative density of the ratio between IDO
and β-actin bands.
Toxoplasma gondii proliferation in HeLa cells after
pretreatment with ZnPPIX or hemin
In order to verify if ZnPPIX or hemin acts directly on
the parasite, T. gondii proliferation in HeLa cells was an-
alyzed. For this purpose, T. gondii 2 F1 tachyzoites (3 ×
106 parasites/well/0.2 mL) were incubated with RPMI
medium containing Na2CO3 + NaCl (vehicle), ZnPPIX
or hemin in different concentrations (1, 5, and 10 μM)
for 1 h at 37 °C and 5% CO2. Next, parasites were
centrifuged (720 × g, 5 min) and the resulting pellet was
resuspended in RPMI medium with 2% FCS. The para-
sites were added to HeLa cell monolayer into 96-well
plates (2 × 104 cells/well/0.2 mL). After 24 h of infection,
the cells were analyzed for T. gondii intracellular prolif-
eration using the colorimetric β-galactosidase assay [49].
Statistical analysis
Statistical analyses were carried out using GraphPad
Prism 5 software (GraphPad Software, San Diego, CA,
USA). Data were expressed as mean ± S.D. of experimen-
tal groups. The comparisons between C57BL/6 and
BALB/c mice were analyzed by the Student’s t test,
whereas comparisons between different experimental
conditions within each mouse lineage were analyzed by
one-way ANOVA and Bonferroni multiple comparison
post-test. For in vitro experimental analyses, compari-
sons in relation to control were performed by one-way
ANOVA and Dunnett post-hoc test. Differences were
considered statistically significant when P < 0.05.
Results
T. gondii infection induces HO-1 activity predominantly in
BALB/c mice
In order to verify whether T. gondii infection is able to
induce HO-1 activity, the bilirubin levels were measured
in serum samples of BALB/c and C57BL/6 mice at 12
dpi. The inhibitory (ZnPPIX) or inducer (hemin) effect
in the HO-1 activity was also analyzed. Infected BALB/c
and C57BL/6 mice show higher serum bilirubin levels
than uninfected/untreated controls (P < 0.01), indica-
ting that T. gondii infection induced HO-1 activity
(Figure 1a). The serum bilirubin levels decreased after
treatment with ZnPPIX in both infected mouse lineages,
although statistical significance was reached only in
BALB/c mice (P < 0.01), indicating that the drug was
able to reduce the HO-1 activity. When infected animals
were treated with hemin, the bilirubin serum levels in-
creased in comparison with uninfected/untreated mice
(P < 0.01), indicating that the drug was able to increase
the enzyme activity. However, hemin-treated BALB/c
mice presented bilirubin levels similar to vehicle-treated
animals, whereas hemin-treated C57BL/6 mice show in-
creased bilirubin levels in comparison with their vehicle
counterparts. In all experimental conditions, except for
ZnPPIX treatment, C57BL/6 mice present lower serum
bilirubin levels than BALB/c mice (P < 0.05; Figure 1a).
Inhibition of HO-1 activity induces increased morbidity
scores in T. gondii-infected C57BL/6 mice
The effect of the HO-1 activity during T. gondii infection
was evaluated by clinical parameters as morbidity
scores and body weight changes from baseline. Infected
C57BL/6 mice showed more pronounced mean morbid-
ity scores (Figure 1b) and significant body weight loss
(P < 0.05; Figure 1c) in relation to BALB/c mice. C57BL/
6 mice treated with ZnPPIX present increased morbidity
scores as compared with vehicle- or hemin-treated ani-
mals or with BALB/c mice in all conditions, although
statistical significance was not reached (Figure 1b). Also,
the treatment with ZnPPIX or hemin shows no signifi-
cant body weight changes among mice inside each
lineage (Figure 1c).
HO-1 activity is involved in the control of T. gondii
infection mainly in the lung
The tissue parasitism was assessed by determination of
cyst-like structure and parasitophorous vacuole numbers
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in the peripheral organs and brain (Figure 2). On day 12
of T. gondii infection, C57BL/6 mice presented higher
parasitism in the lung than BALB/c mice when treated
with vehicle or ZnPPIX (P < 0.05; Figure 2a). ZnPPIX-
treated C57BL/6 and BALB/c mice presented a signifi-
cant increase in the parasite load in the lung (P < 0.01).
The hemin treatment was able to decrease the parasit-
ism in the lung of C57BL/6 mice related to vehicle-
treated mice, despite not being statistically significant.
In the small intestine, C57BL/6 mice present higher
parasitism compared with BALB/c mice when treated
with vehicle or ZnPPIX (P < 0.05; Figure 2b). The induc-
tion or reduction of HO-1 activity did not interfere with
parasite control in this organ in BALB/c mice. In
C57BL/6 mice, however, the induction of the enzyme ac-
tivity by hemin treatment was able to decrease parasite
load in the small intestine (P < 0.01), whereas the reduc-
tion of HO-1 activity by ZnPPIX treatment did not alter
the parasite burden in this organ (Figure 2b).
In the liver, BALB/c and C57BL/6 mice showed low
parasite burden regardless of HO-1 activity (Figure 2c).
However, vehicle-treated C57BL/6 mice present higher
liver parasitism than vehicle-treated BALB/c mice (P <
0.05; Figure 2c). HO-1 activity did not alter the parasite
burden in the brain of BALB/c or C57BL/6 mice on 12
dpi (Figure 2d), and C57BL/6 mice present higher brain
tissue parasitism compared with BALB/c mice when
treated with vehicle or ZnPPIX (P < 0.05; Figure 2d).
The histological changes in the lung and small intes-
tine of infected mice were also investigated, since these
organs presented higher tissue parasitism on 12 dpi. The
lung of BALB/c and C57BL/6 mice present lesions that
were constituted by inflammatory exudates of mononu-
cleated cells within the alveolar walls, enlarging the pul-
monary septum (Figure 2e, Figure 2f ). The lesions were
significantly higher in the lung of C57BL/6 compared
with BALB/c mice (P < 0.05; Figure 2i). On 12 dpi, the
small intestine of C57BL/6 mice presented lesions that
Figure 1 Bilirubin serum levels (a), morbidity score (b), and body weight changes (c) of infected mice. BALB/c and C57BL/6 mice were
infected with 5 T. gondii cysts and treated with the inhibitor (ZnPPIX, 10 mg/kg/day) or inducer (hemin, 5 mg/kg/day) of HO-1 activity or vehicle
(Na2CO3 + NaCl). Bilirubin levels were measured in sera of infected mice by an analytic kit as an indicative of HO-1 activity. Clinical parameters
were observed daily until 12 dpi. Data are representative of at least two independent experiments of at least five mice per group. *Statistically
significant differences between different treatment conditions of BALB/c and C57BL/6 mice (ANOVA and Bonferroni multiple comparison post-
test, P < 0.05). #Statistically significant differences between the two mouse lineages submitted to the same treatment conditions (Student’s t test,
P < 0.05).
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were characterized by infiltration of mononuclear
cells into lamina propria (LP), epithelium and sub-
mucosa (Figure 2g). BALB/c mice presented smaller
inflammatory changes in the organ compared with
C57BL/6 mice in the same experimental condition
(P < 0.05; Figure 2g, Figure 2h, Figure 2j). In some
areas of the small intestine of C57BL/6 mice, in-
creased thickness of the intestinal villi was observed.
Interestingly, the inhibition or induction of HO-1 did
not significantly alter the severity of the lesions in
comparison with vehicle-treated and infected mice
within the same lineage (Figure 2j).
Figure 2 Tissue parasitism and histological changes of infected BALB/c and C57BL/6 mice. Both mice lineages were orally infected with 5
T. gondii cysts and treated with ZnPPIX (10 mg/kg/day), hemin (5 mg/kg/day) or vehicle (Na2CO3 + NaCl). The tissue parasitism in the lung (a), small
intestine (b), liver (c) and brain (d) was detected by immunohistochemestry staining and scored by counting the number of parasitophorous vacuoles
and cyst-like-structures per 50 microscopic fields in the lung and the small intestine or per tissue section in the liver and in the brain. Representative
photomicrographs of histological changes of BALB/c and C57BL/6 mice (e,f) and inflammatory score in the lung (g) assessed by H&E staining.
Representative photomicrographs of histological changes of BALB/c and C57BL/6 mice (h,i) and inflammatory score in the small intestine (j). Data are
representative of at least two independent experiments of five mice per group that provided similar results. *Statistically significant differences between
experimental conditions in the same lineage of mice (ANOVA and Bonferroni multiple comparison post-test, P < 0.05). #Statistically significant
differences between the two mouse lineages submitted to the same treatment conditions (Student’s t test, P < 0.05).
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T. gondii infection increases IFN-γ, IL-10 and IDO mRNA
expression in the lung of C57BL/6 mice
As HO-1 activity seems to be involved in the control of
parasite burden in the lung of BALB/c and C57BL/6 mice,
expression of TNF-α, IFN-γ, TGF-β and IL-10 mRNA was
measured in this site at 12 dpi (Figure 3a-d). In addition,
HO-1 and IDO mRNA expression was measured in
infected mice treated with ZnPPIX or hemin (Figure 3e,
Figure 3f). T. gondii infection was able to increase pulmon-
ary IFN-γ, IL-10 and IDO messages in C57BL/6 mice and
to decrease pulmonary TGF-β mRNA expression in
BALB/c mice (P < 0.05). The ZnPPIX treatment induced
higher TNF-α and IFN-γ mRNA expression in both mouse
lineages, and higher IL-10, HO-1 and IDO mRNA expres-
sion in C57BL/6 mice in comparison with uninfected/
untreated controls (P < 0.05). When compared with
vehicle-treated infected mice, the ZnPPIX treatment in-
duced higher TNF-α, IL-10 and HO-1 mRNA expression
in C57BL/6 mice only (P < 0.05). TGF-β mRNA expression
was not significantly changed with the ZnPPIX treatment
in both mouse lineages. The hemin treatment induced
higher TNF-α, IFN-γ, IL-10 and IDO mRNA expression in
Figure 3 Cytokines, HO-1 and IDO mRNA expression in the lung of T. gondii infected mice. BALB/c and C57BL/6 mice were infected with
5 T. gondii cysts by oral route and treated with ZnPPIX (10 mg/kg/day), hemin (5 mg/kg/day) or vehicle (Na2CO3 + NaCl) and analyzed at 12 dpi.
The relative levels of TNF-α (a), IFN-γ (b), TGF-β (c), IL-10 (d), HO-1 (e) and IDO (f) gene expression were calculated by reference to the β-actin in
each sample, using the threshold cycle (Ct) method. Data are representative of at least two independent experiments of five mice per group.
*Statistically significant differences between experimental conditions in the same lineage of mice (ANOVA and Bonferroni multiple comparison
post-test, P < 0.05). #Statistically significant differences between the two mouse lineages submitted to the same treatment conditions (Student’s t
test, P < 0.05).
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C57BL/6 mice and lower TGF-β mRNA expression in
BALB/c mice, when compared with uninfected/untreated
controls (P < 0.05). Also, hemin-treated C57BL/6 >mice
show increased TNF-α, IFN-γ and TGF-β mRNA expres-
sion in comparison with the vehicle treatment, and in-
creased IFN-γ and decreased IL-10 mRNA expression in
comparison with ZnPPIX treatment (P < 0.05). HO-1
mRNA expression was not significantly changed with the
hemin treatment in both mouse lineages.
When comparing both mouse lineages, C57BL/6 mice
present higher mRNA expression of all analyzed cyto-
kines and HO-1 than BALB/c mice, when treated with
ZnPPIX or hemin (P < 0.05). IDO mRNA expression in
C57BL/6 mice was not changed with the treatments and
was similar to that of BALB/c mice.
T. gondii infection does not induce significant changes in
the HO-1 or IDO mRNA expression in the small intestine
of BALB/c or C57BL/6 mice
Since the induction of HO-1 activity by hemin treatment
was able to reduce parasite replication in the small intes-
tine of C57BL/6 mice, we investigated the mRNA
Figure 4 Cytokines, HO-1 and IDO mRNA expression in the small intestine of T. gondii infected mice. BALB/c and C57BL/6 mice were
infected with 5 T. gondii cysts by oral route and treated with ZnPPIX (10 mg/kg/day), hemin (5 mg/kg/day) or vehicle (Na2CO3 + NaCl) and
analyzed at 12 dpi. The relative levels of TNF-α (a), IFN-γ (b), TGF-β (c), IL-10 (d), HO-1 (e) and IDO (f) gene expression were calculated by
reference to the β-actin in each sample, using the threshold cycle (Ct) method. Data are representative of at least two independent experiments
of five mice per group. *Statistically significant differences between experimental conditions in the same lineage of mice (ANOVA and Bonferroni
multiple comparison post-test, P < 0.05). #Statistically significant differences between the two mouse lineages submitted to the same treatment
conditions (Student’s t test, P < 0.05).
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expression of cytokines (TNF-α, IFN-γ, TGF-β and IL-10)
and enzymes (HO-1 and IDO) in the small intestine of
T. gondii-infected animals treated with ZnPPIX or hemin.
T. gondii infection was not able to change significantly
the cytokine and enzyme messages in the small intestine
in both mouse lineages on 12 dpi (Figure 4). When ani-
mals were treated with ZnPPIX, however, C57BL/6 mice
show higher IFN-γ and IDO mRNA expression as com-
pared with uninfected/untreated or vehicle-treated
infected animals (P < 0.05). On the contrary, ZnPPIX-
treated BALB/c mice show increased HO-1 mRNA
expression in comparison with uninfected/untreated
animals (P < 0.05). The hemin treatment of BALB/c mice
induced higher IL-10 mRNA expression compared with
uninfected/untreated mice (P < 0.05) and decreased
HO-1 mRNA expression in relation to ZnPPIX-treated
animals (P < 0.05). In C57BL/6 mice, the hemin treat-
ment induced a decrease of IFN-γ and IDO mRNA
expression compared with ZnPPIX-treated animals
(P < 0.05). When the mouse lineages were compared,
C57BL/6 mice show higher TNF-α mRNA expression
than BALB/c when treated with hemin, and higher IFN-
γ and IDO mRNA expression when treated with ZnPPIX
(P < 0.05).
HO-1 expressing cells are increased in the lung of BALB/c
and C57BL/6 mice during T. gondii infection
HO-1 expressing cells (HO-1+) were determined by im-
munohistochemistry in pulmonary and intestinal tissues
of infected BALB/c and C57BL/6 mice. T. gondii infection
increased the number of HO-1+ cells in the lungs of
BALB/c and C57BL/6 mice compared with untreated/un-
infected mice, although with statistical significance only in
C57BL/6 mice (P < 0.05; Figure 5a, Figure 5b). The treat-
ment with ZnPPIX did not alter the amount of HO-1+
cells in the lung and small intestine of both mouse line-
ages. On the contrary, the hemin treatment of BALB/c
mice induced higher numbers of HO-1+ cells compared
with untreated/uninfected controls or vehicle- or ZnPPIX-
treated BALB/c mice (P < 0.05). Hemin-treated C57BL/6
mice show lower number of HO-1+ cells compared with
BALB/c mice (P < 0.05), whereas vehicle-treated C57BL/6
mice present higher HO-1+ cells than BALB/c mice under
the same conditions (P < 0.05; Figure 5b).
In the small intestine, T. gondii infection did not alter
the number of HO-1+ cells in both mouse lineages, but
the ZnPPIX treatment reduced HO-1+ cells in infected
BALB/c mice as compared with untreated/uninfected
controls (P < 0.05; Figure 5c, Figure 5d).
Figure 5 Immunoperoxidase staining of HO-1 in the lung and small intestine of T. gondii infected mice. BALB/c and C57BL/6 mice were
orally infected with 5 T. gondii cysts and treated with ZnPPIX (10 mg/kg/day), hemin (5 mg/kg/day) or vehicle (Na2CO3 + NaCl) and analyzed at
day 12 pi. Representative photomicrographs of lung of hemin-treated mice (a) and small intestine of untreated/uninfected mice (c). The images
were captured using a 10 × objective. The data were obtained by counting the number of HO-1 positive cells per tissue section of the lung (b)
and small intestine (d) using a 40 × objective. Data represent the median with interquartile range of each experimental condition in two
independent experiments. *Statistically significant differences between the experimental conditions within the same mouse lineage (P < 0.05,
Kruskal Wallis test and Dunn multiple comparison post-test); #Statistically significant differences between the two mouse lineages (P < 0.05,
Mann–Whitney test).
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T. gondii infection increases the IDO expression in the
lungs and small intestine mainly in C57BL/6 mice
In order to verify the effect of T. gondii infection and
HO-1 activity in the IDO protein expression in the lungs
and small intestine of mice, tissue samples obtained on
12 dpi were submitted to western blot analyses. Both
mouse lineages presented a trend to higher IDO levels
in the lungs compared with untreated/uninfected con-
trols (Figure 6a, Figure 6b). ZnPPIX-treated BALB/c mice
presented higher levels of IDO protein compared with
uninfected/untreated controls and hemin-treated animals
(P < 0.05; Figure 6b). On the contrary, when analyzing
infected C57BL/6 mice, the hemin treatment induced
higher IDO protein expression in the lungs compared with
untreated/uninfected controls and BALB/c mice in the
same condition (P < 0.05; Figure 6b).
The IDO protein expression was also measured in the
small intestine of mice and it was verified that the infec-
tion did not induce IDO in the small intestine of BALB/
c mice, irrespective that the animals were treated or not
with ZnPPIX or hemin (Figure 6c, Figure 6d). However,
hemin treatment of infected C57BL/6 mice induced
higher IDO protein expression as compared with
untreated/uninfected controls or vehicle- or ZnPPIX-
treated mice (P < 0.05; Figure 6c, Figure 6d).
ZnPPIX and hemin do not act directly on T. gondii
To determine whether ZnPPIX and hemin could inter-
fere in T. gondii replication, parasites were treated with
the drugs before infection of Hela cells. An additional
figure file shows that parasites previously treated with
different concentrations of ZnPPIX or hemin presented
similar proliferation in relation to parasites pretreated
with vehicle only. In addition, comparison between the
drugs shows that T. gondii proliferation was similar in
both treatments (see Additional file 1).
Discussion
The HO-1 enzyme is induced in many inflammatory dis-
orders caused by protozoan parasites, such as L. chagasi
[50], L. pfanoi [41], Plasmosdium chabaudi [51], P.
berghei [39] and T. cruzi [42]. Thus, we were interested
in knowing whether HO-1 could also participate in the
immune response to T. gondii infection. Our results
show that the HO-1 activity is enhanced during experi-
mental toxoplasmosis, as demonstrated by the higher
serum bilirubin levels in infected mice as compared to
uninfected controls. Interestingly, HO-1 activity was
higher in BALB/c mice, a lineage considered more resist-
ant to chronic T. gondii infection compared with the
susceptible C57BL/6 lineage. On the contrary, inhibition
Figure 6 Detection of IDO in the lung (a,b) and small intestine (c,d) of T. gondii infected mice. BALB/c and C57BL/6 mice were orally
infected with 5 T. gondii cysts and treated with ZnPPIX (10 mg/kg/day), hemin (5 mg/kg/day) or vehicle (Na2CO3 + NaCl) and analyzed at day 12
pi. Protein extracts obtained from tissue samples were submitted to Western blotting assay for detection of IDO expression. Representative
Western blotting for IDO and β-actin in the lung (a) and small intestine (c) and densitometric analyses showing the relative density of the
respective proteins obtained by the ratio between IDO/β-actin bands in the lung (b) and small intestine (d). Data are representative of at least
two independent experiments of five mice per group. *Statistically significant differences between experimental conditions in the same lineage of
mice (ANOVA and Bonferroni multiple comparison post-test, P < 0.05). #Statistically significant differences between the two mouse lineages
submitted to the same treatment conditions (Student’s t test, P < 0.05).
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of HO-1 activity by ZnPPIX treatment induced more
pronounced morbidity scores and body weight loss in
the susceptible rather than resistant mouse lineage. Ac-
cordingly, in our previous study [47], we demonstrated
that T. gondii infection induces higher inflammatory le-
sions in peripheral organs of C57BL/6 compared with
BALB/c mice. It is noteworthy that in the present study,
we used a low dose of infection (5 cysts of the ME49
strain) and stopped the experiment at 12 days post-
infection, when the animals, particularly of the C57BL/6
mouse lineage, had high morbidity scores. T. gondii
experimental infections in different mouse lineages used
doses ranging from 1 to 100 cysts of different strains
(P-Br and ME49) of T. gondii [43,44,52]. In these studies,
a reduction in survival starting from the 8th-10th day
post-infection and increased inflammatory changes even
with the lowest dose used in the highly susceptible
mouse lineage (C57BL/6), as we observed in our investi-
gation, was demonstrated. Thus, we decided to use 5
T. gondii cysts to infect animals.
Since the anti-inflammatory effects of HO-1 have been
extensively characterized [53], we hypothesized that the
inhibition of HO-1 activity by ZnPPIX treatment would
increase inflammatory changes in T. gondii infection,
while the enzyme induction by hemin would attenuate
the histological changes induced by the parasite. Unex-
pectedly, the induction or inhibition of HO-1 activity at
levels obtained in our experimental procedure did not
alter the inflammatory lesions in the organs of both
BALB/c and C57BL/6 mice at 12 dpi. Previous studies in
experimental cerebral malaria demonstrated that the in-
hibition of HO-1 or HO-1 deletion in resistant BALB/c
mice led to disruption of the blood brain barrier and
brain microvascular congestion with activated leukocytes
and red blood cells [39]. In susceptible C57BL/6 mice,
the induction of HO-1 by cobalt protoporphyrin-IX
(CoPPIX) reduced blood brain barrier disruption and
abolished brain microvascular congestion [39]. Likewise,
during Plasmodium infection, the liver of Hmox-/-
(BALB/c or C57BL/6) mice presented increased number
and size of inflammatory foci and proinflammatory cells
compared with Hmox+/+ mice [40], and HO-1 expres-
sion in the liver was associated with decreased necrosis
in DBA/2 mice [51]. These results reflect that different
protozoan parasites induce diverse immune response
and, in the case of T. gondii infection, the HO-1 activity
did not interfere with the inflammatory alterations in-
duced by the parasite.
The HO-1 inhibition by ZnPPIX treatment induced
higher parasitism in the lungs at 12 dpi in both mouse
lineages compared with hemin or vehicle treatment,
although the parasitism was higher in C57BL/6 than
BALB/c mice. The treatment with hemin was able to
decrease the parasite load in the lung of C57BL/6 mice.
Also, T. gondii infection induced increased amounts of
HO-1+ cells in the lung of both mouse lineages, pre-
dominantly in C57BL/6 mice. In the small intestine, high
parasite load was seen in C57BL/6 mice and the HO-1
induction by hemin treatment was able to decrease the
parasitism. Interestingly, this effect was not due to direct
action on the parasite, since in vitro experiments showed
that T. gondii proliferation was not changed after para-
site pretreatment with hemin or ZnPPIX. Similar results
were found in T. cruzi-infected C57BL/6 mice, since the
HO-1 induction by CoPPIX reduced parasitemia and
tissue parasitism [42]. On the contrary, HO-1 over-
expression in mice induced an increase in P. burghei
liver burden, and treatment of mice with CO, an end-
product of HO-1 enzymatic activity, enhanced parasite
burden, suggesting that the anti-inflammatory properties
of HO-1 were favorable to this parasite replication [40].
Another study demonstrated that ZnPPIX treatment did
not alter parasite replication in experimental cerebral
malaria [39].
Related to cytokine mRNA expression in the lung and
small intestine, it was observed that T. gondii-infected
C57BL/6 mice presented higher levels of TNF-α and
IFN-γ expression in the lung on 12 dpi compared with
BALB/c mice as previously shown [47]. These data were
in accordance with previous studies that showed high
serum levels of pro-inflammatory cytokines, such as
IFN-γ, TNF-α and IL-6 in infected BALB/c mice [54].
The increased production of pro-inflammatory cytokines
in C57BL/6 mice could be related to intense histological
changes and accentuated clinical parameters. Accord-
ingly, C57BL/6 mice infected orally with the 76 K strain
of T. gondii showed higher serum levels of TNF-α and
IFN-γ at 9 dpi and increased weight loss compared with
BALB/c mice [55]. Recently, it was demonstrated that
HO-1 induction by treatment with CoPPIX did not alter
the production of IFN-γ by splenocytes stimulated with
T. cruzi antigen at 9 dpi [42]. Our results show that the
drugs have a different effect in T. gondii-infected organs;
the ZnPPIX or hemin treatment increased TNF-α and
IFN-γ expressions in the lung of infected C57BL/6 mice
whereas the hemin treatment diminished the parasite
load in the organ, hypothesizing that the mechanisms
controlling the parasite induced by hemin are independ-
ent of these two cytokines. Regarding the small intestine,
the HO-1 activity did not interfere with the expression
of pro-inflammatory cytokines in BALB/c mice on 12
dpi. Conversely, ZnPPIX-treated C57BL/6 mice presen-
ted higher levels of IFN-γ expression in the organ in
relation to the other treatments, but this elevated cyto-
kine expression was not sufficient to control the parasite
in the organ.
Previous studies have reported that spleen cells from
T. gondii-infected mice produce IL-10 at 7 dpi [56].
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Moreover, TGF-β and IL-10 mRNA levels were higher in
the peripheral lymph node cells of heart transplanted
mice treated with CoPPIX, and treatment with HO-1 in-
hibitor (ZnPPIX) decreased IL-10 expression in these
animals [57]. In the present study, T. gondii infection in-
duced higher levels of IL-10 mRNA in the lung of
C57BL/6 mice, with no difference in the small intestine.
The ZnPPIX treatment increased the IL-10 mRNA ex-
pression in the lung of C57BL/6 mice. T. gondii infection
did not alter significantly TGF-β expression in the lungs
of C57BL/6, but decreased its expression in the lungs of
BALB/c mice; and no alteration was observed in the
small intestine compared with uninfected mice in the
two lineages. Since there was no difference in histo-
logical changes among mice infected and treated or not
with ZnPPIX/hemin, we suggest that IL-10 and TGF-β
are not involved in the control of pathology or parasit-
ism in the lungs and small intestine of infected mice in
these experimental conditions. Accordingly, Paiva et al.
[42] demonstrated that conventional T. cruzi elimination
mechanisms are not involved in the reduction of parasit-
ism induced by CoPPIX.
Previous studies have demonstrated that the hemin
treatment increases IDO and HO-1 protein expression
in bone marrow-derived dendritic cells and the ZnPPIX
treatment abrogated IDO expression in LPS-stimulated
dendritic cells in vivo and in vitro [58]. It is well known
that restriction of available tryptophan due to degrad-
ation by IDO leads to the control of T. gondii replication
in vitro [23,59,60]. Additionally, IDO inhibition during
toxoplasmosis led to 100% mortality, with increased
parasite burden in the brain [61]. In this context, we in-
vestigated the HO-1 mRNA expression in the lung and
observed that the infection induced HO-1 expression in
the organ of C57BL/6 mice, and higher IDO expression
than uninfected mice in both mouse lineages. Interest-
ingly, ZnPPIX treatment induced higher HO-1 mRNA
expression in the lungs of C57BL/6 mice compared
with uninfected or vehicle-treated infected mice. Since
ZnPPIX inhibits HO-1 activity competitively [62], an
enhanced HO-1 transcription could be a cellular mech-
anism in response to low levels of functional HO-1
protein.
Previous investigations demonstrated high levels of
IDO expression and tryptophan degradation in the lungs
of C57BL/6 mice during acute T. gondii infection
[24,25]. However, in our investigation, the HO-1 activity
did not alter the IDO mRNA expression in the lungs of
infected mice from both lineages, although higher levels
of IDO protein were observed in C57BL/6 mice under
hemin treatment. This additional induction of IDO by
hemin in the lungs of infected mice, above that is nor-
mally induced by infection, seemed to be involved in the
control of the parasite in C57BL/6 mice. Regarding the
resistant BALB/c mice, our findings suggest that baseline
levels of HO-1 protein are required for the control of
parasitism in the lung, since HO-1 inhibition increased
T. gondii replication. However, this mechanism seems to
be independent of IDO, as demonstrated by higher IDO
protein expression in the lung of BALB/c mice treated
with ZnPPIX. In this context, the exact role of HO-1 in
this process remains to be elucidated.
Although IDO expression in the small intestine has
not been completely elucidated during T. gondii infec-
tion, other studies have demonstrated that IDO is im-
portant during inflammatory responses in this site
reviewed by [63]. This enzyme has a protective role in
Citrobacter rodentium enteric bacterial pathogen infec-
tion [64]. When analyzing the small intestine of BALB/c
mice, our results suggest that HO-1 and IDO mecha-
nisms are not crucial to control T. gondii in this resistant
mouse lineage. Conversely, our results show that treat-
ment with hemin, despite not interfering with this en-
zyme mRNA expression, induces high levels of IDO
protein in the organ of C57BL/6 mice, and reduced
T. gondii replication. Interestingly, HO-1 expression was
similar in all treatment conditions. However, bilirubin
levels indicate that HO-1 activity is increased in mice
treated with hemin, suggesting that the mechanisms in-
volved in controlling T. gondii growth in the small intes-
tine are at least partially associated with HO-1 activity.
Taken together, our data suggest that HO-1 activity is
involved in the control of T. gondii infection in the lung
of BALB/c and C57BL/6 mice; and hemin, a HO-1 in-
ducer can be involved at least in part in the control of
parasite load in the small intestine of C57BL/6 mice.
However, the exactly HO-1-mediated mechanisms of
controlling T. gondii in the lung and small intestine, two
important sites of infection, are incompletely known and
remain to be established.
Additional file
Additional file 1: T gondii intracellular proliferation in HeLa cells
after parasite treatment with ZnPPIX, hemin or vehicle. Tachyzoites
of T. gondii 2 F1 strain were treated for 1 h with different concentrations
of ZnPPIX or hemin or vehicle. After 24 h of infection, the experiment
was analyzed for T. gondii intracellular proliferation determined by a
colorimetric microtiter assay using β-galactosidase-expressing tachyzoites.
Data are expressed as mean ± SD of the number of tachyzoites calculated
in relation to a reference curve and are representative of two
independent experiments performed in quadruplicate.
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